RespiGam polyclonal antibody: Will start a Phase III trial

MedImmune Inc. (MEDI), Gaithersburg, Md. Product: RespiGam polyclonal antibody Indication: Respiratory syncytial virus infection in children born prematurely or with bronchopulmonary dysplasia Status:...